Composition

Each mL of solution contains 150 mg of Emicizumab* Each vial of 1 mL contains 150 mg of Emicizumab at a concentration of 150 mg/mL. *Emicizumab is a humanised monoclonal modified immunoglobulin G4 (IgG4) antibody produced using recombinant DNA technology in mammalian Chinese Hamster Ovary (CHO) cells  

ATC Code

B02BX06  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 mL x 1's (in clear glass vial)  

Product Description

Solution for injection. Colourless to slightly yellow solution

Manufacturer Name

Chugai Pharma Manufacturing Co. Ltd Utsunomiya Plant

Manufacturer Country

JAPAN  

Approval Date

2023-11-05  

Expiry Date

2028-10-30